Genzyme Carticel Dropped First-Line Indication Made Up Under 12% Of Sales

The dropped first-line indication of Genzyme Tissue Repair's Carticel knee cartilage repair product represented less than 12% of sales of the product, or less than $2 mil., the company maintains.